Founded with the mission to store biomolecules for future advancements, Cache is a financial technology startup focused on pioneering precision medicine and biological computing. The company believes that nucleic acids are the new bits of the 21st century, aiming to harness the information stored in them to revolutionize healthcare and biological research. Cache offers services that facilitate the storage and management of biomolecular data, targeting markets in precision medicine and biotech industries.
Cache has garnered attention from notable investors and industry leaders who recognize its innovative approach to merging fintech with biotech. The company has achieved significant milestones in developing technologies that could transform how biological data is utilized in medical research and treatment. By focusing on the intersection of finance and biotechnology, Cache is making a substantial impact on the future of healthcare and biological sciences.